Stephen L Graziano, MD, 315 464-4353

Stephen L Graziano, MD
Appointed 12/10/07
2272 Regional Oncology Center
750 East Adams Street
Syracuse, NY 13210
315 464-4353

Current Appointments

Hospital Campus

  • Downtown

Clinical Section Affiliations

  • Medicine: Hematology and Oncology
  • Upstate Cancer Center: Medical Oncology

Research Programs and Affiliations

  • Cancer Research Institute
  • Medicine

Clinic/Unit

Education & Fellowships

  • Fellowship: University Hospital, SUNY Health Science Center at Syracuse, 1985
  • Residency: University Hospital, SUNY Health Science Center at Syracuse, 1982
  • Internship: University Hospital, SUNY Health Science Center at Syracuse, 1980
  • MD: University of Minnesota Medical School, 1979

Clinical Interests

  • Prognostic Factors in Patients with Non-Small Cell Lung Cancer; lung cancer clinical trials; participation in Cancer and Leukemia Group B studies.

Research Interests

  • Participation in Cancer and Leukemia Group B with  J. Bogart, L. Kohman, S. Lemke, J. Wright, B. Poiesz, K. Zamkoff, S. Grethlein and T. Coyle.

Clinical Trials

  • AACRU RC1126: A Randomized Phase II Trial of Erlotinib Alone or in Combination with Bevacizumab in Patients with Non-Small Cell Lung Cancer and Activating Epidermal Growth Factor Receptor Mutations
    Read more
  • CALGB 30901: Randomized Phase II Study of Maintenance Pemetrexed Versus Observation for Patients with Malignant Pleural Mesothelioma without Progression After First-line Chemotherapy
    Read more
  • ECOG E5508-Randomized Phase III Study of Maintenance Therapy with Bevacizumab, Pemetrexed, or a Combination of Bevacizumab and Pemetrexed Following Carboplatin, Paclitaxel and Bevacizumab for Advanced Non-Squamous NSCLC.
    Read more
  • GSK Protocol BRF113928: A Phase II study of the BRAF inhibitor dabrafenib as a single agent and in combination with the MEK inhibitor trametinib in subjects with BRAF V600E mutation positive metastatic (stage IV) non-small cell lung cancer
    Read more
  • RTOG 1306 - A Randomized Phase II Study of Individualized Combined Modality Therapy for Stage III Non-Small Cell Lung Cancer (NSCLC)
    Read more

Specialties & Certification

  • Internal Medicine
  • Oncology
  • Hematology

Diseases & Conditions Treated

  • All Cancers and Hematological Conditions
  • Lung Cancer
  • Mesothelioma

Treats

  • Adults

Treatments/Services

  • Apheresis
  • Blood Transfusion
  • Bone Marrow Aspiration
  • Bone Marrow Biopsy
  • Bone Marrow Transplantation (BMT)
  • Chemotherapy
  • Clinical Trials
  • Conscious Sedation
  • Infusional Therapies
  • Lumbar Puncture
  • Paracentesis
  • Stem Cell Collection Procedures
  • Stem Cell Transplantation
  • Thoracentesis

Current Hospital Privileges

  • Upstate University Hospital

Publications

Link to PubMed External Icon (Opens new window. Close the PubMed window to return to this page.)

Research Abstract

Clinical Profile Shortcut: http://www.upstate.edu/findadoc/grazians
Faculty Profile Shortcut: http://www.upstate.edu/faculty/grazians